Peter A. Kouides MDMary M. Gooley Hemophilia Center Inc., Rochester, NY; Rochester General Hospital; University of Rochester School of Medicine and Roswell Park Memorial Cancer Institute, Rochester, New York
Dr. Kouides is Medical and Research director of the Mary M. Gooley Hemophilia Center. He is Clinical Professor of Medicine at the University of Rochester School of Medicine. In his nearly 30 years of affiliation with the Mary M. Gooley HTC, Dr. Kouides has served as principal investigator (PI) on a number of retrospective and prospective studies focused on the gynecological and obstetrical complications of von Willebrand disease (VWD) and a local PI on numerous hemophilia surveillance and treatment studies. Dr. Kouides has been co-chair of the Centers of Disease Control Universal Data Collection study of women with bleeding disorders and member of the International Society of Thrombosis and Hemostasis (ISTH) Women’s Health Issues Scientific Subcommittee and presently an appointed member of the VWF subcommittee. He is section co-author of the American Society of Hematology (ASH) Self-Assessment Program chapter on Women with Hemostasis and Thrombosis issues. He is a member of the VWD guideline working group of ASH/ISTH/NHF/WFH and member of the NHF Medical and Scientific Advisory Committee. He is also a member of the medical advisory committee of the National Blood Clot Alliance and the Foundation for Women and Girls with Blood Disorders medical advisory board and mentor of their Learning Action Network. Dr. Kouides is immediate past-president of the Thrombosis and Hemostasis Societies of North America. He also directs the World Federation of Hemophilia twinning program between the Mary M. Gooley Hemophilia Center initially with Bishkek, Kyrgyzstan 2009-2013 and with Kathmandu, Nepal since 2014.